Integra LifeSciences Holdings Corporation Stock Analysis & AI Score
Integra LifeSciences Holdings Corporation (IART) has an ST Score of 53.7 (B-), driven by its Profitability (A) and held back by its Growth (D+). Analysts rate it Buy with a $20.50 price target (+29.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Integra LifeSciences Holdings Corporation (IART) has an ST Score of 53.7 (B-), driven by its Profitability (A) and held back by its Growth (D+). Analysts rate it Buy with a $20.50 price target (+29.1% upside).
- Strongest
- ProfitabilityA
- Weakest
- GrowthD+
All factor grades
- ProfitabilityA
- ValuationB+
- MomentumB-
- Financial StrengthC
- ForecastC
- GrowthD+
- Piotroski5/9
Contact
IART stock: frequently asked questions
What is IART's ST Score?
Integra LifeSciences Holdings Corporation (IART) has an ST Score of 53.7 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IART a buy, hold, or sell?
Analysts rate IART a Buy, with a price target of $20.50 (+29.1% vs the current price). Our ST Score grades it B- (53.7/100). The ST Score is a data-driven signal, not a recommendation.
What are IART's factor grades?
Valuation B+, Profitability A, Financial Strength C, Momentum B-, Growth D+, Forecast C.
What is IART's valuation grade?
Integra LifeSciences Holdings Corporation (IART) earns a valuation grade of B+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IART's growth grade?
Integra LifeSciences Holdings Corporation (IART) earns a growth grade of D+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IART's profitability grade?
Integra LifeSciences Holdings Corporation (IART) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IART's financial strength grade?
Integra LifeSciences Holdings Corporation (IART) earns a financial strength grade of C, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IART?
The average analyst price target for Integra LifeSciences Holdings Corporation (IART) is $20.50 from 26 analysts, which is +29.1% versus the recent price of $15.88.
What is IART's Piotroski score?
Integra LifeSciences Holdings Corporation (IART) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.